What Borderline Personality Disorder Actually Is

Borderline personality disorder is a psychiatric condition characterized by pervasive instability in mood, relationships, self-image, and behavior. It affects roughly 1.6–5.9% of the population (prevalence estimates vary by study) and is significantly more prevalent in clinical settings — approximately 20% of psychiatric inpatients meet criteria for BPD.

The DSM-5 criteria require five of nine features: frantic efforts to avoid abandonment, unstable and intense relationships that alternate between idealization and devaluation, identity disturbance, impulsivity in at least two self-damaging areas, recurrent suicidal or self-harming behavior, emotional instability (intense reactivity), chronic feelings of emptiness, inappropriate or uncontrolled anger, and transient stress-related paranoia or severe dissociation.

What this looks like in a person’s life: relationships that cycle rapidly between intense connection and intense conflict; emotional states that can shift dramatically within hours; decisions made impulsively that are later regretted; self-harm as a way of managing overwhelming emotion; a persistent uncertainty about who they are, what they value, and what they want; and a terror of abandonment that can make reasonable separations feel catastrophic. BPD develops in the context of a combination of biological predispositions (emotional sensitivity, reactivity) and environmental invalidation — environments where emotional experiences were chronically discounted, punished, or dismissed.

The Stigma Problem — and Why It Causes Real Clinical Harm

BPD carries a level of stigma within clinical settings that is frankly documented in the research literature. Studies show that clinicians with BPD patients report higher frustration, lower empathy, and more negative attributions compared to patients with other psychiatric diagnoses. The label has historically functioned as a way of marking patients as difficult or manipulative rather than as a description of a specific, treatable clinical condition.

This stigma has consequences. Patients with BPD are more likely to be undertreated, to receive inadequate pain management in medical settings, and to be discharged from psychiatric care for “splitting” behaviors or emotional volatility. The behaviors that clinicians find most difficult — the crises, the self-harm, the intensity of relational demands — are symptoms of the disorder, not character flaws.

The characterization of BPD patients as manipulative deserves direct refutation. Suicidal behavior and self-harm in BPD are not primarily efforts to control others — they’re emergency regulation strategies deployed when emotional pain exceeds the person’s capacity to tolerate it without behavioral intervention. For patients in East Texas who have received this diagnosis, a fresh evaluation that treats symptoms as symptoms — not personality failings — is what effective care looks like.

Evidence-Based Treatment for BPD: What Actually Works

BPD has strong evidence for treatment — better evidence than many other personality disorders. The intervention with the most robust support is Dialectical Behavior Therapy (DBT), developed by Marsha Linehan specifically for BPD. DBT combines individual therapy, group skills training, phone coaching, and therapist consultation to build four skill domains: mindfulness, distress tolerance, emotion regulation, and interpersonal effectiveness.

Clinical trials show that DBT reduces suicidal behavior, self-harm, psychiatric hospitalizations, and dropout from treatment — while improving quality of life and social functioning. Full DBT programs are intensive — weekly individual therapy plus weekly group — and access in East Texas is limited, but DBT-informed approaches have broader availability. Other evidence-supported therapies include Mentalization-Based Therapy (MBT) and Schema Therapy.

Medication’s role. There is no FDA-approved medication specifically for BPD. Medications are used to target co-occurring symptoms: antidepressants for depression, mood stabilizers or atypical antipsychotics for emotional dysregulation and impulsivity, antipsychotics for perceptual disturbances. Medication reduces the severity of the symptom environment in which therapy happens — but doesn’t change the core features of BPD on its own. At ETX Psychiatry, we provide the medication management component and coordinate actively with therapists delivering DBT or DBT-informed therapy.

Getting Psychiatric Care for BPD in East Texas

ETX Psychiatry evaluates and manages medication for patients with BPD and complex presentations involving BPD features. We approach BPD with the clinical lens it deserves: a serious, treatable condition with real evidence-based interventions — not a label for difficult patients. A first evaluation will cover your full psychiatric history, current symptom burden, self-harm and suicidal history (assessed without judgment), functional impairment, and prior treatment experiences.

For BPD specifically, the medication plan is adjunctive to therapy — we’re explicit about that. We’ll work with you to identify DBT-trained therapists in the region and, where available via telehealth, across Texas. We accept Medicare, Aetna, Blue Cross Blue Shield, Cigna/Evernorth, Optum, UnitedHealthcare, UMR, and Ambetter. Our clinic is at 100 Independence Pl, Suite 405, Tyler, TX 75703. To schedule, Call (430) 288-5800(430) 288-5800 or request an appointment online. We serve Tyler, Longview, Lufkin, Nacogdoches, and the surrounding East Texas region. BPD is treatable. The stigma around it isn’t your fault, and it isn’t a reason to go without care.